explore -WSS

explore

author：fashion 2025-10-08 16:51:04 - browse：43935

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： What the airline industry can learn from medicine

WSS

Childhood vaccination ad campaign launches in the U.K.

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Infectious disease expert Jeanne Marrazzo assumes Fauci role

The high personal cost of affirmative action for Black doctors

National panel will explore requiring free Covid tests

Mega Millions pot grows to $1.25 billion after no winner

entertainment

explore

hotspot

Supreme Court strikes down use of affirmative action

5 important ways Henrietta Lacks changed medical science

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cholera vaccine supplies dangerously low, outbreaks surging

Tori Bowie and the unacceptable rates of Black maternal death

Infectious disease expert Jeanne Marrazzo assumes Fauci role

As demand for Covid shots wanes, Moderna seeks its next success

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

United colonoscopy coverage change 'may cost lives,' doctors say

Vertex non

hotspot

Medicare Advantage isn’t working — for anyone

Adults seen as increasingly susceptible to measles

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Ohio train derailment: Experts on toxic chemical risks

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Ohio train derailment: Experts on toxic chemical risks

focus

hotspot

focus

entertainment